Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 InsmedAkcea TherapeuticsForty SevenPacira BiosciencesArvinas
SymbolNASDAQ:INSMNASDAQ:AKCANASDAQ:FTSVNASDAQ:PCRXNASDAQ:ARVN
Price Information
Current Price$24.20$16.38$48.79$42.82$47.38
52 Week RangeBuyBuyBuyBuyBuy
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$43.43$34.67$44.10$55.46$50.00
% Upside from Price Target79.46% upside111.64% upside-9.61% downside29.52% upside5.53% upside
Trade Information
Market Cap$2.26 billion$1.61 billion$2.10 billion$1.95 billion$1.64 billion
Beta3.121.443.591.312.69
Average Volume1,366,169258,797603,318520,205294,247
Sales & Book Value
Annual Revenue$136.47 million$488.54 millionN/A$421.03 million$14.32 million
Price / Sales15.843.15N/A4.27111.66
CashflowN/AN/AN/A$1.60 per shareN/A
Price / CashN/AN/AN/A26.80N/A
Book Value$2.70 per share$3.10 per share$4.29 per share$8.44 per share$4.22 per share
Price / Book8.965.28N/A5.0711.23
Profitability
Net Income$-324,280,000.00$-225,820,000.00$-70,370,000.00$-11,020,000.00$-41,480,000.00
EPS($3.01)$0.48($3.75)$0.86($25.45)
Trailing P/E RatioN/A35.61N/AN/AN/A
Forward P/E RatioN/AN/AN/A25.04N/A
P/E GrowthN/AN/AN/A$0.90N/A
Net Margins-186.37%8.35%N/A-2.62%-157.34%
Return on Equity (ROE)-94.35%11.29%-63.94%10.81%-31.57%
Return on Assets (ROA)-35.12%9.59%-54.76%4.71%-21.20%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio1.19%0.04%0.01%0.98%0.03%
Current Ratio6.97%6.46%7.48%3.79%6.79%
Quick Ratio6.70%6.26%7.48%3.25%6.79%
Ownership Information
Institutional Ownership PercentageN/A22.26%70.79%N/A89.42%
Insider Ownership Percentage4.95%4.10%37.40%5.80%31.77%
Miscellaneous
Employees3732485751883
Shares Outstanding89.34 million93.90 million42.28 million42.03 million33.75 million
Next Earnings Date5/5/2020 (Estimated)5/13/2020 (Estimated)3/26/2020 (Estimated)5/7/2020 (Estimated)3/24/2020 (Estimated)
OptionableOptionableOptionableNot OptionableOptionableNot Optionable
Comparison Ideas:
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel